Description
Tirzepatide – Dual Incretin Receptor Research Compound | Phærma Grade
Tirzepatide is a synthetic peptide investigated in laboratory settings for its activity as a dual agonist of the GLP-1 and GIP receptor pathways. It has been the subject of research in models examining energy balance, glycemic modulation, and adipose tissue response.
Studies in controlled, non-clinical environments have explored tirzepatide’s effects in relation to:
- Peptide-based modulation of glucose homeostasis
- Appetite signaling pathways in animal models
- Incretin system behavior under induced metabolic stress
Each 10mg vial contains lyophilized tirzepatide, suitable for in vitro biochemical assays or preclinical metabolic research protocols conducted by qualified institutions.
Compound Details
- Format: Lyophilized peptide
- Purity: ≥99% (HPLC verified)
- Molecular Formula: C231H371N69070
- CAS: [2023788-19-2]
- Storage: -20°C; protect from light and moisture
Research Use Only
Verasyn Labs provides this compound exclusively for laboratory based research.
Not for human or animal use.
Not for diagnostic or therapeutic application.
No claims are made regarding safety, efficacy, or medical relevance.